US employers consider cutting health benefits as the costs of weight-loss drugs rise
The rising costs tied to GLP-1 drugs are emerging as a strategic workforce issue.
PBMs
FMI applauds reintroduction of bipartisan PBM reform act
In a statement, FMI highlighted the essential role of supermarket pharmacies and the damaging impact of PBM practices on pharmacy viability.
Senators join on bipartisan bill to curb PBM price abuse
The Protecting Pharmacies in Medicaid Act will require Medicaid’s payments to PBMs to be passed directly to pharmacies, excluding administrative fees.
NACDS pushes for PBM reform as Senate weighs “hotline” process
“The negative impacts of inaction are mounting for Americans and for their pharmacies. Every day of inaction means continued drug-price inflation for people.“